The ROX index helps identify patients with pneumonia and acute hypoxemic respiratory failure on high-flow nasal cannula (HFNC) who are at lower or higher risk of needing intubation, at 2, 6 or 12 hours of therapy.
How to read the result
| Time on HFNC | Lower risk of intubation | HFNC failure predicted |
|---|
| 2 hours | 4.88 or more | Below 2.85 |
| 6 hours | 4.88 or more | Below 3.47 |
| 12 hours | 4.88 or more | Below 3.85 |
Values between the two cut-offs fit neither group. In the validation cohort, patients who failed had a smaller rise in ROX over the first 12 hours, and SpO2/FiO2 weighed more in the index than the respiratory rate. The index should not decide intubation on its own: its accuracy was moderate (AUC 0.68-0.76 in the validation cohort), and it was validated only in patients with pneumonia.
Formula
ROX = (SpO2 ÷ FiO2) ÷ respiratory rate
SpO2 in %, FiO2 as a fraction (0.21-1.0), respiratory rate in breaths per minute. Example: SpO2 92% on FiO2 0.6 with a rate of 30 gives (92 ÷ 0.6) ÷ 30 = 5.11.
Validation
Roca and colleagues derived the index in 157 patients with pneumonia on HFNC in 2 centers; 44 (28%) needed intubation, and a ROX of 4.88 or more at 12 hours went with a lower risk (hazard ratio 0.273). In a multicenter validation cohort of 191 patients, 68 (35.6%) were intubated; 4.88 or more at 2, 6 and 12 hours went with lower risk (hazard ratios 0.434, 0.304 and 0.291), and accuracy rose over time (AUC 0.679 at 2 hours, 0.703 at 6 hours and 0.759 at 12 hours). Both cohorts had pneumonia, and the failure cut-offs are the most specific values found in that population.
References
- Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368-1376. PMID 30576221
- Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016;35:200-205. PMID 27481760